Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma

Journal of Nuclear Medicine

Volumn 38, Issue 9, 1997, Pages 1344-4348

  Reske, Sven N ^a   Grillenberger, Kurt G ^a   Glatting, Gerhard ^a   Port, Matthias ^a   Hildebrandt, Martin ^a   Gansauge, Frank ^a   Beger, Hans Günther ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Chronic mass forming pancreatitis; Glut 1; Pancreatic carcinoma; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GLUCOSE TRANSPORT; HUMAN; MALE; PANCREAS CARCINOMA; PANCREAS SCINTISCANNING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; BLOTTING, NORTHERN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEOXYGLUCOSE; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; MONOSACCHARIDE TRANSPORT PROTEINS; PANCREAS; PANCREATIC NEOPLASMS; PANCREATITIS; POLYMERASE CHAIN REACTION; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030884030     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Warburg O. The metabolism of tumors. New York: Richard R. Smith Inc.; 1931:129-169.
2. Strauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1991;32:623-648.
3. Wahl RL. Positron emission tomography: applications in oncology. In: Murray ICP, Ell PJ, eds. Nuclear medicine in clinical diagnosis and treatment, Vol. 2. Edinburgh: Churchill Livingston; 1994:801-820.
4. Mueckler M. Facultative glucose transporters. Eur J Biochem 1994;219:713-725.
5. Baldwin SA. Mammalian passive glucose transporters: members of an ubiquitous family of active and passive transport proteins. Biochem Biophys Acta 1993;1154:17-49.
6. Flier JS, Mueckler MM, Usher P, Lodish HF. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 1987;235: 1492-1495.
7. Birnbaum MJ, Haspel HC, Rosen OM. Transformation of rat fibroblasts by FSV rapidly increases glucose transporter gene transcription. Science 1987;235:1495-1498.
8. Williams SA, Birnbaum MJ. The rat facilitated glucose transporter gene. Transformation and serum-stimulated transcription initiate from identical sites. J Biol Chem 1988;263:19513-19518.
9. Merrall NW, Plevin R, Gould GW. Growth factors, mitogens, oncogenes and the regulation of glucose transport. Cell Signalling 1993;6:667-675.
10. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989;49:6449-6465
11. Stollfuss JC, Glatting G, Friess H, Kocher F, Beger HG, Reske SN. 2-(Fluorine-18)-Fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation. Radiology 1995;195:339-344.
12. Siebert PD, Larrick JW. PCR mimics: competitive DNA fragments for use as internal standards in quantitative PCS. BioTechniques 1993;14:244-249.
13. Sivitz WI, Lee EC. Assessment of glucose transporter gene expression using the polymerase chain reaction. Endocrinology 1991;128:2387-2394.
14. Sachs L. Angewandte Statistik: anwendung statistischer methoden. Berlin: Springer Verlag, 1992; 580-585.
15. Haspel HC, Wilk EW, Birnbaum MJ, Cushman SW, Rosen OM. Glucose deprivation and hexose transporter polypeptides of murine fibroblasts. J Biol Chem 1986;261: 6778-6789.
16. Kornrumpf D, Schulz HJ. Überexpression des Glut-1 glukosetransporters im menschlichem pankreaskarzinom. Eine immunhistologische Studie [Abstract] Nucl Med 1995; 34:A127.
17. Yamamoto T, Seino Y, Fukumoto H, et al. Overexpression of facilitative glucose transporter genes in human cancer. Biochem Biophys Res Commun 1990;170:223-230.
18. Schek N, Hall BL, Finn OJ. Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in human pancreatic adenocarcinoma. Cancer Res 1988;48:6354-6359.
19. Boado RJ, Black KL, Pardridge WM. Gene expression of Glut-3 and Glut-1 glucose transporters in human brain tumors. Mol Brain Res 1994;27:51-57.
20. Mellanen P, Minn H, Grénman R, Härkönen P. Expression of glucose transporters in head-and-neck tumors. Int J Cancer 1994;56:622-629.
21. Brown RS, Wahl RL. Overexpression of Glut-1 glucose transporter in human breast cancer. Cancer 1993;72:2979-2985.
22. Bares R, Klever P, Hauptmann S, et al. F-18-fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Radiology 1994;192:79-86.
23. Wahl RL. Targeting glucose transporters for tumor imaging: "sweet" idea, "sour" result. J Nucl Med 1996;37:1038-1041.
24. Ahn, YS, Rempel A, Zerban H, Bannasch P. Overexpression of glucose transporter isoform Glut-1 and hexokinase I in rat renal oncocytic tubules and oncocytomas. Virchows Arch 1994;425:63-68.
25. Shinohara Y, Yamamoto K, Kogure K, Ichihara J, Terada H. Steady state transcript levels of the type II hexokinase and type 1 glucose transporter in human tumor cell lines. Cancer Lett 1994;82:27-32.
26. Rempel A, Mathupala SP, Griffin CA, Hawkins AL, Pedersen PL. Glucose metabolism in cancer cells: amplification of the gene encoding type II hexokinase. Cancer Res 1996;56:2468-2471.
27. Weber G. Enzymology of cancer cells (second of two parts). N Engl J Med 1977;296:541-551.
28. Tabata T, Fujimori T, Maeda S, Yamamoto M, Saitoh Y. The role of Ras mutation in pancreatic cancer, precancerous lesions and chronic pancreatitis. Int J Pancreatol 1993;14:237-244.
29. Braams JW, Pruim J, Freling NJM, et al. Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med 1995;36:211-216.
30. Laubenbacher C, Saumweber D, Wagner-Manslau C, et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med 1995;36:1747-1457.
31. Kan O, Baldwin SA, Whetton AD. Apoptosis is regulated by the rate of glucose transport in an interleukin 3-dependent cell line. J Exp Med 1994;180:917-923.